Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Allozyne> ?p ?o. }
Showing items 1 to 58 of
58
with 100 items per page.
- Allozyne abstract "Allozyne is a clinical stage biotechnology company headquartered in Seattle’s biotech and high tech innovation corridor. Its lead product AZ01 is a long acting interferon beta for the treatment of the relapsing remitting form of multiple sclerosis, a chronic degenerative disease characterized by demyelination of nerve fibers leading to severe nerve damage and increasing disability. Multiple sclerosis is estimated to affect 400,000 individuals in the US alone and 2.5 million worldwide. AZ01 is currently undergoing Phase I clinical trials in the US. Preclinical data indicates that AZ01 has the potential to be dosed once monthly compared to the current standard of care dosed anywhere from once daily to once per week.Allozyne was founded in 2005 by Caltech researchers and was incubated by Accelerator Corporation.".
- Allozyne foundationPlace MPM_Capital.
- Allozyne foundedBy David_A._Tirrell.
- Allozyne foundedBy William_Andrew_Goddard_III.
- Allozyne foundingYear "2005".
- Allozyne industry Biotechnology.
- Allozyne locationCity Seattle.
- Allozyne type Public_company.
- Allozyne wikiPageExternalLink www.allozyne.com.
- Allozyne wikiPageExternalLink www.allozyne.com.
- Allozyne wikiPageID "27932300".
- Allozyne wikiPageRevisionID "590546354".
- Allozyne foundation "2005".
- Allozyne founder "William A. Goddard III, David A. Tirrell, Dee Datta,PhD".
- Allozyne hasPhotoCollection Allozyne.
- Allozyne homepage www.allozyne.com.
- Allozyne industry Biotechnology.
- Allozyne locationCity Seattle.
- Allozyne locationCountry "USA".
- Allozyne logo File:New_Horizontal_Logo.png.
- Allozyne name "Allozyne Inc.".
- Allozyne slogan "Emerging Technologies in Protein Therapeutics".
- Allozyne type Public_company.
- Allozyne subject Category:Companies_based_in_Seattle,_Washington.
- Allozyne subject Category:Pharmaceutical_companies_of_the_United_States.
- Allozyne point "47.63415 -122.326789".
- Allozyne type Abstraction100002137.
- Allozyne type CompaniesBasedInSeattle,Washington.
- Allozyne type Company108058098.
- Allozyne type DrugCompany108002578.
- Allozyne type Group100031264.
- Allozyne type Institution108053576.
- Allozyne type Organization108008335.
- Allozyne type PharmaceuticalCompaniesOfTheUnitedStates.
- Allozyne type SocialGroup107950920.
- Allozyne type YagoLegalActor.
- Allozyne type YagoLegalActorGeo.
- Allozyne type YagoPermanentlyLocatedEntity.
- Allozyne type Agent.
- Allozyne type Company.
- Allozyne type Organisation.
- Allozyne type Organization.
- Allozyne type Agent.
- Allozyne type SocialPerson.
- Allozyne type Thing.
- Allozyne type SpatialThing.
- Allozyne comment "Allozyne is a clinical stage biotechnology company headquartered in Seattle’s biotech and high tech innovation corridor. Its lead product AZ01 is a long acting interferon beta for the treatment of the relapsing remitting form of multiple sclerosis, a chronic degenerative disease characterized by demyelination of nerve fibers leading to severe nerve damage and increasing disability. Multiple sclerosis is estimated to affect 400,000 individuals in the US alone and 2.5 million worldwide.".
- Allozyne label "Allozyne".
- Allozyne sameAs m.0cm8p3j.
- Allozyne sameAs Q4733261.
- Allozyne sameAs Q4733261.
- Allozyne sameAs Allozyne.
- Allozyne lat "47.63415".
- Allozyne long "-122.326789".
- Allozyne wasDerivedFrom Allozyne?oldid=590546354.
- Allozyne homepage www.allozyne.com.
- Allozyne isPrimaryTopicOf Allozyne.
- Allozyne name "Allozyne Inc.".
